Venovo
Payments companies reported to CMS as associated with Venovo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Venovo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Venovo
These are the largest totals companies reported as associated with Venovo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Matthew Tiede | Wyoming, MI | Diagnostic Radiology | $4,858.87 |
| Efthymios Avgerinos | Pittsburgh, PA | Vascular Surgery | $4,000.00 |
| Glenn Jacobowitz | New York, NY | Vascular Surgery | $4,000.00 |
| Erin Murphy | Charlotte, NC | Vascular Surgery | $3,356.85 |
| Ramesh Gowda | New York, NY | Interventional Cardiology | $2,527.78 |
| Steven Elias | Englewood, NJ | Vascular Surgery | $2,136.92 |
| William Marston | Chapel Hill, NC | Vascular Surgery | $2,136.92 |
| Antonios Gasparis | Huntington, NY | Vascular Surgery | $2,000.00 |
| Ruth Bush | Galveston, TX | Vascular Surgery | $2,000.00 |
| Jeffrey Silpe | New Hyde Park, NY | Vascular Surgery | $1,717.41 |
Prescribed Venovo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.